Patient guides
Stem Cell Therapy Risks, Suitability & Recovery
Questions to ask before any cell collection, injection or infusion.
There is no universal “safe stem cell treatment” and no universal recovery schedule. Suitability depends on the diagnosis, the actual product, the procedure and your medical history.
Start with an independent assessment
Bring your diagnosis, relevant scans and laboratory reports to an appropriately qualified clinician. Ask which standard treatments remain reasonable and what would happen if you did not proceed. A clinic’s willingness to treat you is not an independent assessment of likely benefit.
Give the treating team a complete medication list, allergies, previous operations and significant medical conditions. Ask what findings would make you ineligible. Do not stop prescribed medication on the basis of a website or travel coordinator’s message.
Which risks should be discussed?
FDA reports concerning unapproved regenerative products include serious infections, inflammatory or immune reactions, abnormal tissue growth and other harms. These reports do not provide a complication rate for the clinics in this directory, but they show why product-specific safeguards matter. An invasive procedure can also carry risks from collection, anesthesia and administration. FDA patient safety information.
Ask the clinician to separate risks of the underlying operation from risks introduced by cell preparation or administration. Request the frequency and severity of events in the evidence for the exact protocol, rather than accepting a generic “low risk” label.
What is a meaningful suitability assessment?
A useful assessment explains the diagnosis, the goal, alternatives, reasons not to proceed and any additional information required. It should leave room for the answer to be “this is not appropriate for you.” A questionnaire reviewed only by a sales coordinator is not the same as a medical recommendation by the clinician responsible for treatment.
Separate the sources of risk
Collection, processing and administration create different questions. Ask about sterility, cell identity, contamination testing, anesthesia, injection or infusion complications and emergency arrangements. Using your own cells does not make a procedure automatically safe. Regulators have reported serious harm involving unapproved products.
For fat transfer, discuss the surgical risks separately from the uncertain additional value of cell enrichment. Ask the clinician which adverse events have occurred with the exact protocol being offered and how they were managed.
Get a recovery and escalation plan
Before paying, obtain written instructions covering activity, wound care if relevant, follow-up appointments and whom to contact after hours. Ask the team to define symptoms that require urgent local medical attention. Do not rely on an overseas clinic’s chat response during an emergency.
Arrange a clinician at home who can review records and ongoing symptoms. Confirm whether remote follow-up is available, who provides it and which complications require an in-person assessment. Recovery promises should be specific to your procedure and medical assessment.
Sources and further reading
- About Stem Cells — Unproven treatmentsSource checked 9 October 2026.
- US FDA — Warning about harm from unapproved productsSource checked 9 October 2026.
- American Society of Plastic Surgeons — Fat transfer breast augmentation risksSource checked 9 October 2026.
- CDC — Medical tourismSource checked 9 October 2026.
- US FDA — Important patient information about regenerative therapiesSource checked 9 October 2026.